Overview

Evaluation of Low Blood Sugar Events in Participants With Diabetes (MK-0431-402)

Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
This is a multicenter, observational, retrospective and cross-sectional study to be conducted in a cohort of consecutively selected participants with type 2 diabetes mellitus (T2DM) who have been treated with sulphonylurea (SU) monotherapy or SU + metformin (MF) combination therapy by their cardiologist, nephrologist, or family practice doctor for at least 6 months prior to study enrollment. The purpose of the study is to assess treatment patterns, goal attainment rates, long-term diabetes complication rates, and frequency and severity of hypoglycemic episodes among T2DM participants treated in cardiology, nephrology and family practice settings.
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.